Hypercalcemia
-
Subject Areas on Research
- A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.
- A woman with low energy and high calcium.
- Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy.
- An approach to monoclonal gammopathies in the elderly.
- Bisphosphonate-associated arthritis.
- Caspofungin for the treatment of azole resistant candidemia in a premature infant.
- Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
- Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature.
- Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature.
- Drug-induced bone disease.
- Effects of two models of hypercalcemia on renal acid base metabolism.
- Extreme hypercalcemia and electrocardiographic changes.
- Familial hypocalciuric hypercalcemia in the donor and recipient of a living related donor kidney transplant.
- Hypercalcemia following acute renal failure.
- Hypercalcemia in a dialysis patient.
- Hypercalcemia in children.
- Hypercalcemia in patients with advanced chronic renal failure not yet requiring dialysis.
- Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
- Hypercalcemia-induced ST-segment elevation mimicking acute myocardial infarction.
- Hypercalcemia. A complication of advanced chronic liver disease.
- Hyperparathyroidism associated with the enlargement of two or three parathyroid glands.
- Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.
- Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation.
- Managing the complications of plasma cell myeloma.
- Non-autonomy of parathyroid hormone secretion in acute primary hyperparathyroidism.
- Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trial.
- Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.
- Post transplant erythrocytosis in hypercalcemic renal transplant recipients.
- Primary hyperparathyroidism.
- Primary hyperparathyroidism: a new experimental animal model.
- Primary isolated hepatosplenic sarcoidosis mimicking malignancy and causing symptomatic hypercalcaemia.
- Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
- Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.
- Safety and tolerability of high-dose daily vitamin D3 supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetes.
- Skeletal disorders in malignant disease.
- Spontaneous hypercalcemia in patients undergoing dialysis. Etiologic and therapeutic considerations.
- Symposium on renal lithiasis. The challenge of calculi in children.
- The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.
- The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.
- The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type.
- Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
- Urinary cyclic adenosine monophosphate as an aid in the diagnosis of hyperparathyroidism.
- cAMP and calcemia.